Log in to save to my catalogue

Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mo...

Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9cc3cca518f446ec8e34c1d90acbfb4c

Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice

About this item

Full title

Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice

Publisher

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Journal title

Zhongguo fei ai za zhi, 2021-06, Vol.24 (6), p.394-403

Language

Chinese

Formats

Publication information

Publisher

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

More information

Scope and Contents

Contents

Immune checkpoint inhibitors (ICIs) such as antibodies against programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1), have shown remarkable efficacies in many subtypes of cancers. However, ICIs may also cause severe immune-related adverse events in the recipient patients. Recently, ICI-associated myocarditis have been reported i...

Alternative Titles

Full title

Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9cc3cca518f446ec8e34c1d90acbfb4c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9cc3cca518f446ec8e34c1d90acbfb4c

Other Identifiers

ISSN

1009-3419

E-ISSN

1999-6187

DOI

10.3779/j.issn.1009-3419.2021.102.23

How to access this item